Posts Tagged 'flulaval'

GSK Warned over Vaccine Plant

GlaxoSmithKline received a warning from the U.S. Food and Drug Administration about the conditions at its manufacturing facility in Quebec. The FDA said that the plant violated quality requirements during the manufacturing of its influenza vaccine Flulaval.

The FDA sent a letter to the company on June 12 after an inspection of the plant earlier this year. The investigation found that GSK had not established and followed written procedures to prevent microbiological contamination of ...

continue reading...